Cloned cows cause beef on climate change

UN estimates global meat industry belches out 14.5% of global greenhouse gas emissions

GSK picks tough China path after scandal

New rules to tackle corrupt practices leave drugmaker at a commercial disadvantage, say industry peers

GSK confident of China renaissance

Drugmaker looks to repair reputation shattered by corruption scandal

WEALTH MAGAZINE West Hall Care home Surrey, part of a trend for care catering to wealthy pensioners. Pictured Residents taking part in Tai Chi. Credit: David Parry/ FT
©David Parry

Fears rise for care homes

Chancellor fails to deliver substantial rise in funding

Ingram Pinn illustration, Pfizer
©Ingram Pinn

Big Pharma is addicted to an illusion

Paying high prices for proven drugs and taking a hit to the balance sheet does not avoid the bill

‘Excess winter deaths’ stir NHS fears

Last year’s UK figures highest since beginning of the millennium

Nigeria on track to be polio-free by 2017

Since July 2014, there have been no cases of wild polio, allowing Nigeria to be declared no longer endemic

Political risk clouds Pfizer-Allergan deal

Transaction is seen as vulnerable to change in ‘tax inversion’ law

Corporate tax: The $240bn black hole

Pfizer-Allergan merger is set to increase calls for the US to close inversion loopholes, and for the OECD to get tough on avoidance

Obama should close Pfizer’s tax loophole

Drug company’s tax inversion shows poor corporate citizenship

A false alarm on red meat and cancer

Two large trials have tested for evidence and the WHO ignored both of them, writes Gordon Guyatt

How to avoid ‘retirement shock’

Plan carefully to avoid psychological strain of end to working life

Pfizer seeks US support for Allergan deal

Drugmaker tries to fend off opposition as politicians line up to attack Irish takeover

Four Seasons losses widen as costs rise

UK’s biggest care home operator says it cash for “medium-term”

Pfizer bulks up in era of slimming down

‘Pfizergan’ could eventually be split but not until at least 2018

Pfizer set for windfall with Ireland move

Allergan deal likely to lead to one-off earnings gain of up to $21bn

AstraZeneca sells US rights to Entocort

Drug group continues divestments to focus on core areas

Pfizer and Allergan race to seal deal

Companies set to create the world’s biggest drugmaker

Pfizer tie-up would mark M&A high point

Pharma has seen a vigorous period of dealmaking

Top Allergan investors fret over bid price

Some shareholders keen on Pfizer offer closer to $400 a share


More FT Twitter accounts
Enter job search